MI
OGEN icon

Motiv8 Investments’s Oragenics OGEN Stock Holding History

Motiv8 Investments’s Portfolio OGEN Stock Details OGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$0 Buy
+1
New +$1 ﹤0.01% 962

Other funds holding OGEN

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Motiv8 Investments's OGEN Position: Q4 2025 in Review

Motiv8 Investments opened a new position in Oragenics (OGEN) in Q4 2025: 1 share worth $0. The stake represents ﹤0.01% of the portfolio and ranks #962 among its holdings.

18 funds tracked by Wall St. Rank hold OGEN as of Q4 2025.

  • Motiv8 Investments held 1 share of Oragenics worth $0 as of Q4 2025.
  • Oragenics was a new Motiv8 Investments position in Q4 2025.
  • Oragenics made up ﹤0.01% of Motiv8 Investments's portfolio in Q4 2025, its #962 holding.
  • 18 funds tracked by Wall St. Rank held Oragenics as of Q4 2025.

Based on Motiv8 Investments's 13F filing for Q4 2025, filed 13 Feb 2026.